The House Energy & Commerce/Oversight Subcommittee’s July 18 hearing on the 340B drug discount program suggests that there is serious, bipartisan interest in updating the 1992 legislation that created the program – but that the process will move forward slowly and carefully.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?